Indeed, DKK1 as well as other Wnt antagonists have been shown to inhibit breast cancer progression (Bafico et al., 2004; Cowling et al., 2007; Mikheev et al., 2008; Matsuda et al., 2009). The gene discussed is DKK1; the disease is breast carcinoma.